A simple multiplex PCR for assessing prevalence of extended-spectrum β-lactamases producing Klebsiella pneumoniae in Intensive Care Units of a referral hospital in Shiraz, Iran

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 9, 2013, Pages 703-708

  Ghasemi, Younes ^a,b   Archin, Talieh ^c   Kargar, Mohammad ^c   Mohkam, Milad ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

ESBLs; ICUs; Klebsiella pneumoniae; Multiplex PCR

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CTX M GENE; DNA SEQUENCE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GENE IDENTIFICATION; GENOTYPE; HUMAN; INTENSIVE CARE UNIT; IRAN; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SHV GENE; SPECIES DISTRIBUTION; TEM GENE;

ESBLS; ICUS; KLEBSIELLA PNEUMONIAE; MULTIPLEX PCR;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; IRAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PREVALENCE; REFERRAL AND CONSULTATION;

EID: 84879862780     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60122-4     Document Type: Article

References (27)

1. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P Molecular characterization and epidemiology of extended-spectrum-β- lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Ch 2008, 52(8):2818-2824.
2. Jones RN, Biedenbach DJ, Gales AC Sustained activity and spectrum of selected extended-spectrum β lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000). Int J Antimicrob Ag 2003, 21(1):1-7.
3. Otman J, Perugini ME, Tognim MCB, Vidotto MC Atypical phenotypic characteristics of Klebsiella pneumoniae isolates from an outbreak in a neonatal intensive care unit in Brazil. Braz J Microbiol 2007, 38(2):273-277.
4. Paterson DL, Hujer KM, Hujer AM Extended-spectrum βlactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: Dominance and widespread prevalence of SHV-and CTX-M-type β Lactamases. Antimicrob Agents Ch 2003, 47(11):3554-3560.
5. Nijssen S, Florijn A, Bonten MJM, Schmitz FJ, Verhoef J, Fluit AC Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Ag 2004, 24(6):585-591.
6. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN Prevalence of extended spectrum β lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY antimicrobial surveillance program (1998-99). Diagn Micr Infec Dis 2002, 42(3):193-198.
7. Fang H, Ataker F, Hedin G, Dornbusch K Molecular epidemiology of extended-spectrum β Lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008, 46(2):707-712.
8. Grover SS, Sharma M, Chattopadhya D, Kapoor H, Pasha ST, Singh G Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J Infection 2006, 53(4):279-288.
9. Lal P, Kapil A, Bimal K Occurrence of TEM & SHV gene in extended spectrum β lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 2007, 125(2):173-178.
10. Marra AR, Pereira CAP, Castelo A Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum β lactamase (ESBL) in a hospital with high prevalence of this infection. Int J Infect Dis 2006, 10(1):56-60.
11. Mendonça N, Ferreira E, Louro D, Arsip P, Caniça M Molecular epidemiology and antimicrobial susceptibility of extended-and broad-spectrum β lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int J Antimicrob Ag 2009, 34(1):29-37.
12. Gupta A, Ampofo K, Rubenstein D, Saiman L Extended spectrum lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J Perinatol 2003, 23(6):439-443.
13. Lim KT, Yasin R, Yeo CC, Puthucheary S, Thong KL Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. J Biomed Biotechnol 2009, 2009:1-10.
14. Bradford PA Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14(4):933-951.
15. Bali EB, Aç KL, Sultan N Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum -lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res 2010, 4(8):650-654.
16. Valentina G, Lalitha MK Methods in biochemical identification of bacteria. Myer's and Koshi's manual of diagnostic procedures in medical microbiology and immunology/serology 2001, Department of Clinical Microbiology, Christian Medical College, Vellore. 2nd ed.
17. Steward CD, Rasheed JK, Hubert SK Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the national committee for clinical laboratory standards extended-spectrum β lactamase detection methods. J Clin Microbiol 2001, 39(8):2864-2872.
18. Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemoth 1998, 42(1):49-54.
19. Siegel JD, Rhinehart E, Jackson M, Chiarello L Management of multidrug-resistant organisms in health care settings. Am J Infect Control 2006, 35(2):165-169.
20. Hassanzadeh P, Motamedifar M, Hadi N Prevalent bacterial infections in intensive care units of Shiraz University of Medical Sciences teaching hospitals, Shiraz, Iran. Jpn J Infect Dis 2009, 62(4):249-253.
21. Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N Epidemiology of infections caused by extended-spectrum β lactamase-producing Escherichia coli and Klebsiella spp: a nested case-control study from a tertiary hospital in London. J Hosp Infect 2006, 64(2):115-123.
22. CTX-M genes in Enterobacteriaceae. Apmis 2007, 115(12):1400-1408.
23. Mansouri S, Abbasi S Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta lactamase producing enterobacteriaceae in Southeast Iran. Iran J Med Sci 2010, 35(2):101-108.
24. Mehrgan H, Rahbar M Prevalence of extended-spectrum β lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Ag 2008, 31(2):147-151.
25. Nasehi L, Shah CF, Nikbin VAS, Nematzadeh SH PER, CTX-M, TEM and SHV Beta-lactamases in clinical isolates of Klebsiella pneumoniae isolated from Tehran, Iran. Iran J Bas Med Sci 2010, 13(3):111-118.
26. Ahmed S, Daef E, Badary M, Mahmoud M, Abd-Elsayed A Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum -lactamase producing organisms. BMC Res Notes 2009, 2(1):76-87.
27. Huemer HP, Eigentler A, Aschbacher R, Larcher C Dominance of CTX-M group 1 beta-lactamase enzymes in ESBL producing E. coli from outpatient urines in neighboring regions of Austria and Italy. Cent Eur J Med 2011, 123:41-44.